Physician profile
Michael E Rauser
NPI 1992737498
$3,595.49
in general payments reported to CMS, 2019-2025
23 companies · $694 in 2025
The $694 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $205 · 2021: $218 · 2022: $496 · 2023: $940 · 2024: $644 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,277.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,690.21 | 2019-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Unity |
| Regeneron Healthcare Solutions, INC. | $258.36 | 2022-2024 | Eylea Hd, Eylea |
| Samsara Vision | $180.95 | 2022-2024 | |
| Amgen INC. | $149.26 | 2025 | Tepezza |
| Apellis Pharmaceuticals, INC. | $132.63 | 2022-2025 | Syfovre |
| Carl Zeiss Meditec, INC. | $127.42 | 2019 | |
| Astellas Pharma US INC | $126.92 | 2023-2024 | Izervay |
| Novartis Pharmaceuticals Corporation | $125.42 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $120.61 | 2023-2024 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $98.87 | 2024-2025 | Tecnis Simplicity, Tecnis Iol |
| Allergan, INC. | $97.79 | 2019-2021 | |
| Glaukos Corporation | $86.10 | 2019-2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $81.78 | 2024-2025 | Envista Mx60 Iol, Xiidra, Miebo |
| Ani Pharmaceuticals, INC. | $62.45 | 2025 | Purified Cortrophin Gel, Yutiq |
| Abbvie INC. | $50.18 | 2022-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.25 | 2019-2021 | |
| Oyster Point Pharma, INC. | $33.27 | 2022 | |
| Dompe US, INC. | $29.91 | 2024 | Oxervate |
| Sight Sciences, INC. | $29.37 | 2023 | Omni Surgical System |
| Medtronic, INC. | $22.36 | 2023 | Mazor X System |
| Horizon Therapeutics Plc | $20.53 | 2020 | |
| Aerie Pharmaceuticals, INC. | $19.19 | 2020 | |
| Eyevance Pharmaceuticals LLC | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rauser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.